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Background: High normal values of urine albumin-to-creatinine ratio (UACR) have been reported to have
predictive values for hypertension, incident stroke, and higher mortality in the general population. This study aimed
to investigate the association between normal ranges of UACR and carotid intima-media thickness (CIMT) in adult
population.
Methods: We performed a cross-sectional study in adults aged 45 to 74 years who were living in Namwon
City, South Korea. Both common CIMTs were measured, and mean values were calculated. Normal values of
UACR were defined as <30mg/g and categorized into quintiles; less than 6.50, 6.51-9.79, 9.80-13.49, 13.50-18.89,
and more than 18.90 mg/g. The association between the quintiles of UACR and common CIMT was analyzed
and stratified by sex.
Results: A total of 7555 participants (3084 men and 4471 women) with normal UACR were enrolled in the
present study. Common CIMT was positively and independently associated with increasing quintiles of UACR in
men and women, even after adjusting for potential confounders including age and cardiovascular risk factors.
Compared to the first quintile, the fifth quintile showed odds ratios of 1.80 (95% confidence intervals, 1.26-2.55)
and 1.97 (1.28-3.04) for increased CIMT (>0.9mm) in men and women, respectively.
Conclusion: Higher UACR values within normal ranges (<30 mg/g) were positively and independently
associated with CIMT in a Korean general population, suggesting that higher normal values of UACR might be
a risk marker of subclinical carotid atherosclerosis.
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Atherosclerosis and its associated vascular effects in-
cluding cardiovascular disease (CVD), stroke, peripheral
arterial disease, and end-stage renal disease has become
a leading cause of disability and mortality in both devel-
oped and developing countries [1]. For an effective pre-
vention of vascular diseases, it would be reasonable to
discuss the limitations of conventional risk equations due* Correspondence: jeongsk@jbnu.ac.kr
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reproduction in any medium, provided the orto the increase in obesity, metabolic syndrome, and type
2 diabetes. And it needs to be developed for biomarkers
that are relevant to the risk in those individuals [2].
Elevations in albumin excretion are indicative of glom-
erular injury mainly due to type 2 diabetes or hyperten-
sion [3]. Rather than using 24-hr urine collections, spot
urine tests can determine urinary albumin-to-creatinine
ratios (UACR), making it easier to diagnose and monitor
albuminuria both clinically and in research studies [4].
In addition to renal injury, albuminuria (usually defined
as UACR≥ 30mg/g) has become a biologic marker of
underlying systemic diseases such as atherosclerosis [5].
Albuminuria has also been associated with incident
strokes in various populations [6] and in both diabeticsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dicted hypertension [8], incident stroke [9], and higher
mortality [10] in the general population.
Albuminuria has been associated with carotid intima-
media thickness (CIMT) [11,12], which is a widely
accepted marker of subclinical CVD [13]. Similarly, the
association of normal range UACR values (i.e., <30mg/g)
and CIMT should be studied separately, because the
normal ranges of UACR has been reported to have pre-
dictive values for subsequent hypertension and mortality
[8,10]. In this cross-sectional study, we reported the as-
sociation between normal UACR values (<30mg/g) and
CIMT in an adult Korean population aged 45 to 74
years. To determine the independence of the above asso-
ciation, data were adjusted for cardiovascular risk factors
and estimated glomerular filtration rate (eGFR), which
showed a significant linear relationship with UACR
values when stratified by sex.
Subjects and methods
Study population
The Namwon study is an ongoing prospective study
designed to investigate the prevalence, incidence, and
risk factors for chronic disease in Namwon City, Chon-
buk province, Korea. Demographic data and measure-
ments for the study subjects were as previously reported
[14]. The 2005 census reported 33,068 residents (14,960
men and 18,108 women) aged 45–74 in Namwon City.
From 2004 to 2007, all eligible residents within this age
range were contacted via mail or telephone and were
invited to participate in the study. A total of 10,667 sub-
jects (4,201 men and 6,466 women; response rate 32.3%)
chose to participate in the clinical examinations and
interviews. This study was approved by the institutiona-
lethics committee at Chonbuk National University Hos-
pital, and all participating subjects provided written
informed consent.
Assessments and measurements
The clinical data collected from the subjects included
prior history of CVD, CVD risk factors, and medication
usage. Major cardiovascular risk factors included hyper-
tension (blood pressure ≥140/90mmHg or use of anti-
hypertensive medication), type 2 diabetes (current or
previous use of glucose-lowering medications or fasting
blood glucose >7.0mmol/L (126mg/dL)), and hyperlipid-
emia (previous use of lipid-lowering medications, total
cholesterol ≥6.2mmol/L (240mg/dL), or low density lipo-
protein (LDL) cholesterol ≥4.1mmol/L (160mg/dL)).
Smoking status was divided into 3 categories: current
smokers, former smokers, and nonsmokers. Participants
also answered questions concerning alcohol consumption,
including questions about frequency, duration, amount,
and type of alcohol consumed. Waist circumference wasmeasured at the point midway between the lower rib mar-
gin and the iliac crest with the subject standing. Body mass
index (BMI) was calculated as weight divided by height
squared (kg/m2).
Blood pressure was measured on the right arm with a
standard mercury sphygmomanometer after 5min of rest
in the sitting position. The appearance (phase I) and dis-
appearance (phase V) of Korotkoff sounds were used to
define systolic and diastolic pressure, respectively. Blood
pressure readings were recorded to the nearest even
number, and three readings were taken at 1 min inter-
vals from each participant. The mean value of the three
readings was considered to represent the individual’s
blood pressure.
Blood samples were drawn after a 12-hour overnight
fasting period, and standard techniques were used to
measure serum chemistries and lipids. Serum insulin
was determined by immunoassay using AxSYM (Abbott
Laboratories, IL, USA), and insulin resistance was calcu-
lated using the homeostasis model assessment of the in-
sulin resistance (HOMA-IR) score [15]. Each participant
provided an early morning spot urine sample in a sterile
container at the examination center. Urinary albumin
concentrations were measured using a turbidimetric im-
munoassay, and creatinine concentrations were mea-
sured using the Jaffe method on an automated analyzer
(Hitachi-7600, Hitachi, Ltd). All laboratory procedures
were conducted at the same laboratory. The UACR was
defined as the urinary albumin value divided by the urin-
ary creatinine concentration (mg/g). The eGFR was cal-
culated using the 6-variable Modification of Diet in
Renal Disease (MDRD) equation [16]:
eGFR ¼ 170 serum creatinine0:999  age0:176
 BUN0:170  albumin0:318
 0:762 if the participant was a womanð Þ:
The eGFR is expressed in mL/min/1.73m2, serum cre-
atinine and blood urea nitrogen (BUN) are expressed in
mg/dL, albumin is expressed in g/dL, and age is
expressed in years. Abnormal kidney function was
defined as eGFR <60mL/min/1.73m2.
Details of carotid intima-media thickness (CIMT)
measurements are as previously published [17]. Distal
portions of the common carotid artery (CCA) IMT
were assessed by two certified physicians (S.K.J. and
Y.H.L.) using high-resolution B mode ultrasonography
(SONOACE 9900, Medison, Korea) with an electrical
linear array transducer (7.5MHz). Images of plaque free
regions as well as the thickest areas (>10mm) from the
carotid bulb to the CCA were saved and measured using
SigmaScan Pro Version 5.0.0 (SPSS Inc., Chicago, IL,
USA). CIMT thickening was defined as a mean CIMT
of ≥0.9mm. The correlation coefficients for inter- and
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0.90, respectively.
Statistical analysis
Data are expressed as mean ± standard deviation (SD) or
percentages. Students t-tests were used to analyze differ-
ences between continuous variables, and chi-square tests
were used for categorical variables. According to the
UACR quintile values, means and proportions of CVD
risk factors were calculated using analysis of variance
(ANOVA) or chi-square tests. All analyses were per-
formed after sex stratification. Analysis of covariance
(ANCOVA) was used to evaluate the association be-
tween common CIMT and UACR quintile values. Logis-
tic regression analysis was also used to evaluate the
association between the UACR quintile values and
CIMT thickening, which are presented as odds ratios
(OR) and 95% confidence intervals. All statistical ana-
lyses were conducted using PASW statistics 18 (SPSS
Inc., Chicago, IL, USA).
Results
Among the 10,667 subjects, 7847 (73.6%) were defined
as having UACR values <30mg/g, 2687 (25.2%) had
values >30mg/g, and 133 (1.2%) had unmeasured
UACRs. Among the subjects with a UACR <30mg/g,
292 (3.7%) did not complete subsequent testing includ-
ing carotid ultrasonography or blood chemistry. A total
of 7,555 subjects (70.8%; men: 3,084, women: 4,471) with
UACR values <30mg/g who underwent carotid ultrason-
ography were analyzed in the present study.
The demographic and clinical features of the study
population are presented in Tables 1 and 2 in men and
women, respectively, because all CVD risk factors
showed significant differences between them. Nearly all
CVD risk factors showed significant positive associations
with UACR values in men and women, including age,
hypertension, type 2 diabetes, systolic BP, diastolic BP,
triglycerides, fasting blood sugar, serum creatinine, and
eGFR. On the other hand, proportions of current smo-
kers, hyperlipidemia, BMI, total cholesterol, and HDL-
cholesterol did not show significant associations with
the UACR values. Proportions of current drinkers, waist
circumference, and HOMA-IR were significantly and
positively associated with UACR values only in men.
Higher UACR values within normal ranges were sig-
nificantly and positively associated with distal CIMT in
men and women, as depicted in Figure 1. The mean
value of CIMT was significantly higher in men than
women in each quintile (all p values < 0.001). The asso-
ciations between higher UACR values within normal
ranges and CIMT in men and women were independent,
even after adjusting for age, current smoking status,
current alcohol use, waist circumference, systolic BP,diastolic BP, HOMA-IR, eGFR, triglycerides, fasting
blood glucose, hypertension, type 2 diabetes, and hyper-
lipidemia as shown in Table 3. UACR values were
also independently associated with CIMT thickening
(>0.9 mm) in men and women, as shown in Table 4.
Discussion
Our results demonstrated that common CIMT was posi-
tively associated with UACR values in a Korean popula-
tion aged 45 to 74 years. The UACR values were limited
to less than the recommended cutoff value (30mg/g),
and the associations were adjusted for age and CVD risk
factors in both sexes. UACR values >30mg/g are indica-
tive of renal injury, and kidney disease is an independent
risk factor for the occurrence of vascular diseases [18].
Thus, UACR values less than 30mg/g are likely better
for assessing associations with CIMT and CVD risk fac-
tors to exclude the confounding effects of kidney dis-
ease. No previous study has reported the cross-sectional
association between the UACR values of normal range
and CIMT in detail. There have been two previous stud-
ies that showed the similar results, but one study
included subjects with microalbuminuria [19] and the
other showed the UACR values according to CIMT
thickening only [20].
Carotid IMT and higher UACR values within normal
ranges
The significant association between CIMT and higher
UACR values within normal ranges (<30mg/g) are likely
the result of systemic atherosclerosis, which presents dif-
ferently depending on the organ system. In the kidney,
an increase in the UACR represents a loss of podocytes
and an elevation in angiotensin II [21], while CIMT
thickening is a surrogate marker of macroangiopathy
[22]. The etiology of increases in both UACR and com-
mon CIMT is thought to be endothelial dysfunction
[23,24].
Both the UACR values and CIMT respond similarly to
various therapeutic treatments. Carotid atherosclerosis
has been shown to improve with the use of antihyper-
tensives [25], antiplatelet agents [26], and intensive dia-
betes management [11]. UACR values may also be
lowered with the use of antihypertensives [27], antidia-
betics [28], and exercise [29]. Treatment with angioten-
sin II blockade has shown that carotid atherosclerosis
and UACR values can improve simultaneously [30], sug-
gesting that angiotensin II levels may play a role in ele-
vated UACR values and CIMT.
In the present study, men showed significantly higher
CIMT than women in each quintile of UACR. The simi-
lar findings were also observed in diabetic patients, and
the mean annual progression of CIMT was associated
with age only in men [31]. However, the 10-year risk
Table 1 Cardiovascular risk profiles according to quintiles of UACR in men
UACR, mg/g p*
< 6.50 6.5-9.79 9.80-13.49 13.50-18.89 ≥ 18.90
Number (%) 691 (22.4) 692 (22.4) 641 (20.8) 549 (17.8) 511 (16.6)
Age, y 60.2 ± 8.0 61.0 ± 7.9 62.3 ± 7.4 63.4 ± 7.3 63.4 ± 7.2 < 0.001
Current smoker, % 29.8 35.0 39.6 33.4 33.1 0.287
Current drinker, % 63.6 62.4 66.7 66.9 67.5 0.043
Hypertension, % 31.8 33.7 33.0 41.2 47.0 < 0.001
Type 2 diabetes, % 8.0 8.7 9.8 13.5 16.3 < 0.001
Hyperlipidemia, % 6.5 6.1 7.2 6.7 7.8 0.331
Body mass index, kg/m2 24.0 ± 2.8 23.7 ± 2.7 23.8 ± 2.7 23.8 ± 2.9 24.1 ± 2.8 0.059
Waist circumference, cm 85.5 ± 7.6 84.4 ± 7.3 85.1 ± 7.8 84.7 ± 8.2 86.0 ± 7.8 0.004
Systolic BP, mmHg 121.1 ± 15.9 122.3 ± 15.1 124.3 ± 15.2 127.7 ± 16.2 129.6 ± 15.9 < 0.001
Diastolic BP, mmHg 79.6 ± 9.3 79.6 ± 9.6 79.9 ± 9.3 81.7 ± 9.9 82.1 ± 10.2 < 0.001
Total cholesterol, mmol/L 4.7 ± 0.9 4.7 ± 0.9 4.7 ± 0.9 4.7 ± 0.9 4.8 ± 1.0 0.246
Triglycerides, mmol/L 1.8 ± 1.4 1.7 ± 1.3 1.8 ± 1.3 1.8 ± 1.3 2.0 ± 1.4 < 0.001
HDL cholesterol, mmol/L 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 0.727
FBG, mmol/L 5.7 ± 0.9 5.7 ± 0.9 5.7 ± 1.0 5.8 ± 1.1 6.1 ± 1.6 < 0.001
HOMA-IR 1.4 ± 1.3 1.2 ± 1.1 1.3 ± 1.4 1.2 ± 1.0 1.6 ± 1.9 < 0.001
Serum creatinine, μmol/L 91.5 ± 16.7 87.9 ± 13.3 87.4 ± 13.1 86.0 ± 13.6 86.9 ± 13.6 < 0.001
eGFR, ml/min/1.73m2 83.9 ± 13.0 86.9 ± 14.3 87.0 ± 14.0 88.5 ± 15.4 87.1 ± 14.1 < 0.001
Data are expressed as mean ± standard deviation, unless otherwise indicated. BP, blood pressure; HDL; high-density lipoprotein, FBG, fasting blood glucose;
HOMA-IR; homeostatic model assessment for insulin resistance, eGFR; estimated glomerular filtration rate.
eGFR was calculated using the 6-variable Modification of Diet in Renal Disease (MDRD) formula.
* p-values for analysis of variance (ANOVA) and chi-square tests for trends are shown, as appropriate.
Table 2 Cardiovascular risk profiles according to quintiles of UACR in women
UACR, mg/g p*
< 6.50 6.5-9.79 9.80-13.49 13.50-18.89 ≥ 18.90
Number (%) 798 (17.8) 839 (18.8) 882 (19.7) 928 (20.8) 1024 (22.9)
Age, y 56.8 ± 7.8 58.8 ± 7.9 60.2 ± 7.7 62.0 ± 7.3 62.9 ± 7.3 < 0.001
Current smoker, % 3.4 4.5 2.3 4.0 2.8 0.371
Current drinker, % 38.8 41.1 34.8 35.0 36.8 0.054
Hypertension, % 24.8 27.7 31.6 33.5 42.9 < 0.001
Type 2 diabetes, % 5.1 5.5 7.2 8.3 9.8 < 0.001
Hyperlipidemia, % 11.8 11.5 11.1 12.9 12.4 0.441
Body mass index, kg/m2 24.5 ± 3.0 24.6 ± 3.0 24.6 ± 3.2 24.5 ± 3.1 24.5 ± 3.2 0.969
Waist circumference, cm 86.4 ± 7.9 86.4 ± 8.4 86.4 ± 8.7 86.1 ± 8.8 86.0 ± 8.9 0.714
Systolic BP, mmHg 117.8 ± 16.0 119.6 ± 16.0 121.5 ± 16.7 123.6 ± 17.2 127.2 ± 18.6 < 0.001
Diastolic BP, mmHg 77.2 ± 9.4 77.4 ± 9.0 78.5 ± 9.4 79.4 ± 9.5 80.6 ± 10.8 < 0.001
Total cholesterol, mmol/L 4.9 ± 1.0 4.9 ± 0.9 5.0 ± 0.9 5.0 ± 0.9 5.0 ± 1.0 0.139
Triglycerides, mmol/L 1.5 ± 1.0 1.5 ± 1.0 1.6 ± 1.0 1.7 ± 1.0 1.7 ± 1.4 < 0.001
HDL cholesterol, mmol/L 1.3 ± 0.3 1.3 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.3 ± 0.3 0.400
FBG, mmol/L 5.5 ± 0.7 5.5 ± 0.8 5.5 ± 0.8 5.5 ± 1.0 5.6 ± 1.0 0.001
HOMA-IR 1.4 ± 0.9 1.4 ± 1.3 1.4 ± 1.1 1.4 ± 1.1 1.4 ± 1.2 0.449
Serum creatinine, μmol/L 70.8 ± 9.6 70.2 ± 10.1 68.6 ± 11.5 67.4 ± 9.6 68.1 ± 10.9 < 0.001
eGFR, ml/min/1.73m2 83.8 ± 12.7 84.1 ± 13.0 86.0 ± 14.9 86.2 ± 13.3 85.6 ± 14.5 < 0.001
Data are expressed as mean ± standard deviation, unless otherwise indicated.
* p-values for analysis of variance (ANOVA) and chi-square tests for trends are shown, as appropriate.
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Figure 1 The mean values of common carotid intima-media thickness (CIMT) according to quintiles of normal UACR values in men and
women (both p values < 0.001 by analysis of variance, respectively). Error bars indicate 95% confidence intervals.
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was not different in men and women with an addition of
CIMT to the Framingham Risk Score, which showed
small improvement of limited clinical importance [32].UACR values and cardiocerebrovascular disease risk
factors
Nearly all CVD risk factors showed linear relationships
with UACR values, as presented in Tables 2 and 3.
Among the lipid profiles, triglycerides were independ-
ently associated with the higher UACR values within
normal ranges in both sexes, but total cholesterol and
HDL-cholesterol were not. A recent study showed that
triglycerides were significantly lowered with olmesartan
[33] which supports the proposed interaction between
the renin-angiotensin-aldosterone system and lipid me-
tabolism [34].Table 3 Adjusted mean values of common carotid IMT accord
Adjusted carotid IMTs (Mean± SE, mm) according to
Sex < 6.50 6.5-9.79 9.80-13.49
Men 0.742 ± 0.005 0.753 ± 0.005 0.761 ± 0.005
Women 0.701 ± 0.004 0.711 ± 0.004 0.721 ± 0.004
Data are expressed as mean ± standard error.
Adjusted for age, current smoking status, current alcohol use, waist circumference,
hypertension, type 2 diabetes, and hyperlipidemia.In this study, many of the CVD risk factors studied
were sex specific. In women, UACR values <30mg/g
were not associated with obesity indices (BMI and waist
circumference), whereas significant associations were
observed in men. Obesity has been shown to be an inde-
pendent risk factor for the development of chronic kid-
ney disease as well as poor overall health outcomes [35].
It is important to note, however, that UACR values
<30mg/g should be considered carefully in obese
patients, as muscle mass, which determines the urinary
concentration of creatinine, may be more variable in
obese women than men [36]. Thus, obesity may have a
confounding effect on UACR, particularly in women.
Similar findings have also been reported for microalbu-
minuria [37].
The UACR is a window into the renal artery, which
shares many features with cerebral arteries [38]. The
vascular beds of the brain and kidney have similaring to quintiles of UACR (<30mg/g)
quintiles of UACR (mg/g) p for overall p for linear
13.50-18.89 ≥ 18.90 difference trend
0.764 ± 0.005 0.769 ± 0.006 0.003 < 0.001
0.722 ± 0.004 0.727 ± 0.004 < 0.001 < 0.001
systolic BP, diastolic BP, HOMA-IR, eGFR, triglycerides, fasting blood glucose,
Table 4 Associations between carotid IMT thickening
(>0.9 mm) and quintiles of UACR
Quintiles of
UACR, mg/g
Odds ratio (95% confidence intervals)
Men Women
< 6.50 1.00 1.00
6.5-9.79 1.33 (0.94-1.89) 1.14 (0.70-1.88)
9.80-13.49 1.39 (0.99-1.97) 1.82 (1.16-2.86)**
13.50-18.89 1.63 (1.15-2.55)** 1.61 (1.03-2.52)*
≥ 18.90 1.80 (1.26-2.55)**† 1.97 (1.28-3.04)**†
Adjusted for age, current smoking status, current alcohol use, waist
circumference, systolic BP, diastolic BP, HOMA-IR, eGFR, triglycerides, fasting
blood glucose, hypertension, type 2 diabetes, and hyperlipidemia.
* p < 0.05, ** p < 0.01.
† p< 0.001 by trend test.
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and low impedance with tightly autoregulated perfusion
[39]. In addition to a strong and independent association
with stroke, albuminuria was also independently asso-
ciated with cognitive decline [40,41]. UACR levels not
traditionally considered significant might be used to
identify cerebral arterial dysfunction even before evident
diseases, such as stroke or dementia, are clinically mani-
fested [42].Limitations
There are several limitations of our study. First, due to
the cross-sectional study design, a causal relationship
between UACR values <30mg/g, CVD risk factors, and
CIMT cannot be inferred. Second, a single measurement
of UACR may not adequately characterize in vivo vari-
ability of this value. Although we adjusted for urinary
creatinine excretion, the assessment of albumin excretion
with spot urine tests may be less accurate than 24-hour
urine collections. Third, there might be a potential re-
sidual confounding for the treatment of risk factors,
especially with lipid-modifying therapies, to explain the
discrepant associations between UACR values and lipid
profiles. Finally, the response rate (32.3%) was relatively
low, and the subjects were not randomly selected in our
study. These might result in selection bias and limit the
generalization of the present findings. Although, age and
sex distribution in the study subjects were comparable
with those of the general population, suggesting that the
present study overcame volunteer effects in part.Conclusion
In a population of Korean adults, higher normal values
of UACR were independently and positively associated
with common CIMT, even after adjusting for potential
confounders, suggesting that higher normal values of
UACR might be a risk marker of subclinical carotid
atherosclerosis.Abbreviations
UACR: Urine albumin-to-creatinine ratio; CIMT: Carotid intima-media
thickness; CCA: Common carotid artery; CVD: Cardiovascular disease;
EGFR: Estimated glomerular filtration rate; BMI: Body mass index; HOMA-
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